Protein Characterization Market / Protein Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) & Region - Global Forecast to 2026
Market Growth Outlook Summary
The global protein characterization market growth is primed to transition from $12.6 billion in 2021 to $23.9 billion by 2026, showcasing a strong CAGR of 13.7%. Growth in the protein identification market can mainly be attributed to factors such as rising acceptance of personalized medicine, technological advancement and increased drug discovery & development activities.
To know about the assumptions considered for the study, Request for Free Sample Report
Protein Characterization Market Dynamics
Driver: Increased R&D expenditure for drug discovery and development
The growing emphasis on drug discovery and development has favored the market for protein characterization and identification. Protein analysis is an important stage of pharma and biologic product development to identify potential candidates. Thus, the drive to discover new and advanced drugs has received a significant boost with the acceptance of novel drug therapies. The consequent increase in R&D and expenditure will therefore favor the protein identification and characterization market. According to the EvaluatePharma report, worldwide pharmaceutical R&D spending was valued at USD 136 billion in 2012; this increased to USD 186 billion in 2019.
Opportunity: Emerging markets
The Asia Pacific market is projected to offer growth opportunities for players owing to the rising focus on using protein analysis-based technologies for drug discovery, increasing R&D initiatives to develop innovative proteomic and genomic techniques, diversified healthcare markets, and improving research infrastructure. For instance, In May 2021, Purolite announced a strategic partnership with PharmNXT Biotech to offer Praesto mAb chromatography resin platform to South Korea and Singapore.
Challenge: Dearth of skilled professionals
For protein characterization and identification, sample preparation is a key step in isolating the analyte of interest, which helps eliminate interferences that could affect the result. The lack of knowledge regarding the right choice of technology and sample preparation also affects results and poses several direct and indirect expenses for end users.
By product & service, the consumables segment accounted for the largest share of the protein characterization industry.
On the basis of product & service, the protein characterization market is segmented into consumables, instruments, and services. The consumables segment is further divided into immunoassay consumables, mass spectrometry consumables, chromatography consumables, electrophoresis consumables, and other consumables. The instruments segment is further divided mass spectrometry instrument, chromatography instrument, electrophoresis instrument, label-free detection instrument, spectroscopy instrument, and other instruments. The services segment is further divided based on the applications such as drug discovery & development, clinical diagnosis, and other applications. The consumables segment dominated the market in 2020. The large share of this segment can be attributed to rapid availability of a wide range of reagents and the need for reliable, specific, and rapid detection of diseases at the early stages.
By application, drug discovery & development segment accounted for the largest share of the protein characterization industry.
Based on application, the global protein characterization market is broadly categorized into drug discovery & development, clinical diagnosis, and other applications. The drug discovery & development segment accounted for the largest share in 2020 owing to rising R&D expenditure and increasing number of clinical trials for developing advanced therapeutics.
By end user, the pharmaceutical & biotechnology companies segment accounted for the largest share of the protein characterization industry.
Based on end user, the global protein characterization market is segmented into pharmaceutical & biotechnology companies, academic research institutes, contract research organization (CROs) and other end users. In 2020, the pharmaceutical & biotechnology companies dominated the market owing to growth in drug discovery activity will ensure sustained demand for market technologies.
North America accounted for the largest share of the protein characterization industry.
North America accounted for the largest share of the protein identification market, followed by Europe. The large share of the North American regional segment can be attributed to availability of funds for innovative technologies from government organizations and the growing number of agreements and collaborations among large companies.
To know about the assumptions considered for the study, download the pdf brochure
Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) are the prominent players operating in the protein characterization market.
Scope of the Protein Characterization Industry8[
|
Report Metric |
Details |
|
Market Revenue Size in 2021 |
$12.6 billion |
|
Projected Revenue Size by 2026 |
$23.9 billion |
|
Industry Growth Rate |
poised to grow at a CAGR of 13.7% |
|
Market Driver |
Increased R&D expenditure for drug discovery and development |
|
Market Opportunity |
Emerging markets |
The study categorizes the protein identification market to forecast revenue and analyze trends in each of the following submarkets:
By Product & Service
-
Consumables
- Immunoassay Consumables
- Mass Spectrometry Consumables
- Chromatography Consumables
- Electrophoresis Consumables
- Other Consumables
-
Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Electrophoresis Instruments
- Label-free Detection Instruments
- Spectroscopy Instruments
- Other Instruments Instruments
-
Services
- Drug Discovery & Development
- Clinical Diagnosis
- Other Applications
By Application
- Drug Discovery & Development
- Clinical Diagnosis
- Other Applications
By End User
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutions
- Contract Research Organizations
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- The Middle East and Africa
Recent Developments of Protein Characterization Industry
- In June 2021, Thermo Fisher Scientific launched Orbitrap IQ-X Tribrid mass spectrometer.
- June 2021, Agilent Technologies, Inc. launched Bio LC system based on UPHPLC technology for protein analysis.
- In May 2021, Danaher Corporation and Waters Corporation collaborated to launch Waters ultra-performance liquid chromatography instruments.
- In August 2020, Bruker Corporation collaborated with Utrecht University to develop new methods for studying protein structures and interactions using mass spectrophotometry.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the protein characterization market?
The protein characterization market boasts a total revenue value of $23.9 billion by 2026.
What is the estimated growth rate (CAGR) of the protein characterization market?
The global protein characterization market has an estimated compound annual growth rate (CAGR) of 13.7% and a revenue size in the region of $12.6 billion in 2021.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 53)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 PROTEIN CHARACTERIZATION MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 57)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 PROTEIN IDENTIFICATION MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF PROTEIN CHARACTERIZATION AND IDENTIFICATION IN THE MARKET
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
FIGURE 6 AVERAGE MARKET SIZE ESTIMATION, 2020
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 7 PROTEIN CHARACTERIZATION MARKET: CAGR PROJECTIONS, 2021–2026
FIGURE 8 PROTEIN IDENTIFICATION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 INSIGHTS FROM PRIMARIES
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
2.6.1 COVID-19 SPECIFIC ASSUMPTIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 68)
FIGURE 12 PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 14 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER 2021 VS. 2026 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT: GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 71)
4.1 PROTEIN CHARACTERIZATION MARKET OVERVIEW
FIGURE 16 RISING &&D EXPENDITURE TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: PROTEIN IDENTIFICATION MARKET SHARE, BY PRODUCT & COUNTRY (2020)
FIGURE 17 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
4.3 GLOBAL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 THE CONSUMABLES SEGMENT WILL DOMINATE THE MARKET IN 2026
4.4 PROTEIN CHARACTERIZATION MARKET SHARE, BY END USER, 2020
FIGURE 19 THE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.5 PROTEIN IDENTIFICATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 75)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 PROTEIN CHARACTERIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 PROTEIN IDENTIFICATION MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing acceptance of personalized medicines
FIGURE 22 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–2020
5.2.1.2 Increased R&D expenditure for drug discovery and development
FIGURE 23 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2016
5.2.1.3 Technological advancements
5.2.1.4 Growth in proteomics research
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing prominence of nanoproteomics
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
5.3 IMPACT OF COVID-19 ON THE PROTEIN CHARACTERIZATION MARKET
FIGURE 24 PROTEIN IDENTIFICATION MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021
6 PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE (Page No. - 82)
6.1 INTRODUCTION
TABLE 2 PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 3 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 4 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 5 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 6 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 7 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 8 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 9 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 10 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 11 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 12 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 13 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.2.1 IMMUNOASSAY CONSUMABLES
6.2.1.1 Immunoassay consumables to dominate the consumables market during the forecast period
TABLE 14 IMMUNOASSAY CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 15 IMMUNOASSAY CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 16 NORTH AMERICA: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 17 NORTH AMERICA: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 18 EUROPE: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 19 EUROPE: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 20 ASIA PACIFIC: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 21 ASIA PACIFIC: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.2.2 MASS SPECTROMETRY CONSUMABLES
6.2.2.1 Increased use of mass spectrometry-based approaches supports segment growth
TABLE 22 MASS SPECTROMETRY CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 23 MASS SPECTROMETRY CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 24 NORTH AMERICA: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 25 NORTH AMERICA: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 26 EUROPE: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 27 EUROPE: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 29 ASIA PACIFIC: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.2.3 CHROMATOGRAPHY CONSUMABLES
6.2.3.1 Increasing demand for chromatography reagents and columns for protein analysis to drive segment growth
TABLE 30 CHROMATOGRAPHY CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 31 CHROMATOGRAPHY CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 32 NORTH AMERICA: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 33 NORTH AMERICA: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 34 EUROPE: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 35 EUROPE: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 36 ASIA PACIFIC: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 37 ASIA PACIFIC: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.2.4 ELECTROPHORESIS CONSUMABLES
6.2.4.1 Increasing demand for 2D electrophoresis is driving the adoption of consumables
TABLE 38 ELECTROPHORESIS CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 39 ELECTROPHORESIS CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 41 NORTH AMERICA: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 42 EUROPE: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 43 EUROPE: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 45 ASIA PACIFIC: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.2.5 OTHER CONSUMABLES
TABLE 46 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 47 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 49 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 50 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 51 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 52 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 53 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 54 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 55 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 56 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 57 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 59 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 60 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 61 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 62 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 63 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3.1 MASS SPECTROMETRY INSTRUMENTS
6.3.1.1 Mass spectrometry instruments hold the largest share of the instruments market
TABLE 64 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 65 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 67 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 68 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 69 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 70 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 71 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3.2 CHROMATOGRAPHY INSTRUMENTS
6.3.2.1 Advancements in HPLC for protein characterization drives the market growth
TABLE 72 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 73 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 75 NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 76 EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 77 EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 78 ASIA PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 79 ASIA PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3.3 ELECTROPHORESIS INSTRUMENTS
6.3.3.1 Simplicity and technological advancements in electrophoresis drive market growth
TABLE 80 ELECTROPHORESIS INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 81 ELECTROPHORESIS INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 82 NORTH AMERICA: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 83 NORTH AMERICA: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 84 EUROPE: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 85 EUROPE: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 86 ASIA PACIFIC: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 87 ASIA PACIFIC: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3.4 LABEL-FREE DETECTION INSTRUMENTS
6.3.4.1 Extensive use of label-free detection for biologic and new product development to drive the market
TABLE 88 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 89 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 91 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 92 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 93 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 94 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 95 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3.5 SPECTROSCOPY INSTRUMENTS
6.3.5.1 The ability of MS to identify small amounts of protein from increasingly complex mixtures will drive segment growth
TABLE 96 SPECTROSCOPY INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 97 SPECTROSCOPY INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 98 NORTH AMERICA: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 99 NORTH AMERICA SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 100 EUROPE: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 101 EUROPE: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 102 ASIA PACIFIC: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 103 ASIA PACIFIC: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3.6 OTHER INSTRUMENTS
TABLE 104 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 105 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 106 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 107 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 108 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 109 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 111 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.4 SERVICES
6.4.1 THE INCREASING USE OF PROTEIN IDENTIFICATION AND CHARACTERIZATION SERVICES BY PHARMACEUTICAL AND BIOTECH COMPANIES BOOSTS SEGMENT GROWTH
TABLE 112 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: SERVICES & SERVICE PROVIDERS
TABLE 113 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 114 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 115 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 116 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 117 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 118 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 120 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 121 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 122 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 123 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2017–2020 (USD MILLION)
TABLE 124 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)
TABLE 125 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 126 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 127 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 128 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 129 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 130 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 131 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2017–2020 (USD MILLION)
TABLE 132 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2021–2026 (USD MILLION)
TABLE 133 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 134 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 135 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 136 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 137 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 138 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 139 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2020 (USD MILLION)
TABLE 140 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
TABLE 141 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 142 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 143 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 144 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 145 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 146 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
7 PROTEIN CHARACTERIZATION MARKET, BY APPLICATION (Page No. - 146)
7.1 INTRODUCTION
TABLE 147 PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 148 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
7.2 DRUG DISCOVERY & DEVELOPMENT
7.2.1 INCREASED FOCUS ON DRUG DISCOVERY AND DEVELOPMENT WILL BOOST THE MARKET GROWTH
TABLE 149 GLOBAL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2017–2020 (USD MILLION)
TABLE 150 GLOBAL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)
TABLE 151 NORTH AMERICA: PROTEIN CHARACTERIZATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 152 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 153 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 154 EUROPE: PROTEIN IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 156 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
7.3 CLINICAL DIAGNOSIS
7.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
TABLE 157 PROTEIN CHARACTERIZATION MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2017–2020 (USD MILLION)
TABLE 158 PROTEIN IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2021–2026 (USD MILLION)
TABLE 159 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 160 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 161 EUROPE: MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 162 EUROPE: MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 164 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 165 PROTEIN CHARACTERIZATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2020 (USD MILLION)
TABLE 166 PROTEIN IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
TABLE 167 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 168 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 169 EUROPE: PROTEIN CHARACTERIZATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 170 EUROPE: PROTEIN IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 171 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 172 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
8 PROTEIN CHARACTERIZATION MARKET, BY END USER (Page No. - 158)
8.1 INTRODUCTION
TABLE 173 PROTEIN IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 174 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASED EMPHASIS ON DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
FIGURE 25 ANNUAL DRUG APPROVALS BY THE FDA CDER (2011–2020)
TABLE 175 PROTEIN CHARACTERIZATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2020 (USD MILLION)
TABLE 176 GLOBAL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2026 (USD MILLION)
TABLE 177 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 179 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 180 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 181 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 182 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
8.3 ACADEMIC RESEARCH INSTITUTES
8.3.1 INCREASED FUNDING FOR PROTEOMIC RESEARCH WILL DRIVE THE GROWTH OF THE MARKET
TABLE 183 PROTEIN IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION)
TABLE 184 PROTEIN CHARACTERIZATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION)
TABLE 185 NORTH AMERICA: PROTEIN IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 186 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 187 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 188 EUROPE: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 189 ASIA PACIFIC: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 190 ASIA PACIFIC: MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
8.4 CONTRACT RESEARCH ORGANIZATIONS
8.4.1 INCREASED FOCUS ON THE DEVELOPMENT OF NOVEL DRUGS DRIVING THE MARKET GROWTH
TABLE 191 PROTEIN CHARACTERIZATION MARKET FOR CROS, BY REGION, 2017–2020 (USD MILLION)
TABLE 192 PROTEIN IDENTIFICATION MARKET FOR CROS, BY REGION, 2021–2026 (USD MILLION)
TABLE 193 NORTH AMERICA: MARKET FOR CROS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 194 NORTH AMERICA: MARKET FOR CROS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 195 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 196 EUROPE: MARKET FOR CROS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 197 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 198 ASIA PACIFIC: MARKET FOR CROS, BY COUNTRY, 2021–2026 (USD MILLION)
8.5 OTHER END USERS
TABLE 199 PROTEIN CHARACTERIZATION MARKET FOR OTHER END USERS, BY REGION, 2017–2020 (USD MILLION)
TABLE 200 PROTEIN IDENTIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021–2026 (USD MILLION)
TABLE 201 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 202 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 203 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 204 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 205 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 206 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
9 PROTEIN CHARACTERIZATIONMARKET, BY REGION (Page No. - 174)
9.1 INTRODUCTION
TABLE 207 PROTEIN IDENTIFICATION MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 208 GLOBAL IDENTIFICATION MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: PROTEIN CHARACTERIZATION MARKET SNAPSHOT
TABLE 209 NORTH AMERICA: PROTEIN DENTIFICATION MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 210 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 211 NORTH AMERICA: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 212 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 213 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 214 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 215 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 216 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 217 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 218 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 219 NORTH AMERICA: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 220 NORTH AMERICA: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 221 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 222 NORTH AMERICA: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the protein characterization and identification market during the forecast period
TABLE 223 US: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 224 US: PROTEIN DENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 225 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 226 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 227 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 228 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 229 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 230 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 231 US: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 232 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 233 US: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 234 US: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing focus on patented therapies and diagnostics and increased R&D expenditure promote market growth
TABLE 235 CANADA: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 236 CANADA: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 237 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 238 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 239 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 240 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 241 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 242 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 243 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 244 CANADA: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 245 CANADA: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 246 CANADA: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3 EUROPE
TABLE 247 EUROPE: PROTEIN CHARACTERIZATION MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 248 EUROPE: PROTEIN IDENTIFICATION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 249 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 250 EUROPE: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 251 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 252 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 253 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 254 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 255 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 256 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 257 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 258 EUROPE: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 259 EUROPE: PROTEIN CHARACTERIZATIONMARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 260 EUROPE: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominates the protein characterization and identification market in Europe
TABLE 261 GERMANY: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 262 GERMANY: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 263 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 264 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 265 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 266 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 267 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 268 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 269 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 270 GERMANY: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 271 GERMANY: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 272 GERMANY: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing investment in the biotech industry and surge in the prevalence of chronic diseases to drive market growth
TABLE 273 UK: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 274 UK: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 275 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 276 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 277 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 278 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 279 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 280 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 281 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 282 UK: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 283 UK: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 284 UK: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing personalized medicine to increase the market growth
TABLE 285 FRANCE: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 286 FRANCE: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 287 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 288 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 289 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 290 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 291 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 292 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 293 FRANCE: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 294 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 295 FRANCE: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 296 FRANCE: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growth of the life science industry to expand market growth
TABLE 297 ITALY: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 298 ITALY: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 299 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 300 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 301 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 302 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 303 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 304 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 305 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 306 ITALY: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 307 ITALY: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 308 ITALY: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Innovation and increased R&D funding to maximize market growth
TABLE 309 SPAIN: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 310 SPAIN: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 311 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 312 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 313 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 314 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 315 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 316 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 317 SPAIN: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 318 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 319 SPAIN: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 320 SPAIN: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 321 ROE: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 322 ROE: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 323 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 324 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 325 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 326 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 327 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 328 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 329 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 330 ROE: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 331 ROE: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 332 ROE: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: PROTEIN CHARACTERIZATION MARKET SNAPSHOT
TABLE 333 ASIA PACIFIC: PROTEIN IDENTIFICATION MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 334 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 335 ASIA PACIFIC: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 336 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 337 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 338 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 339 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 340 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 341 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 342 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 343 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 344 ASIA PACIFIC: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 345 ASIA PACIFIC: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 346 ASIA PACIFIC: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Government initiatives and foreign investments for R&D to prompt market growth
TABLE 347 CHINA: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 348 CHINA: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 349 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 350 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 351 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 352 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 353 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 354 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 355 CHINA: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 356 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 357 CHINA: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 358 CHINA: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 The growth of the biopharmaceutical sector will promote market growth in Japan
TABLE 359 JAPAN: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 360 JAPAN: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 361 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 362 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 363 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 364 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 365 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 366 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 367 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 368 JAPAN: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 369 JAPAN: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 370 JAPAN: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government initiatives and increased proteomics research to boost the market growth
TABLE 371 INDIA: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 372 INDIA: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 373 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 374 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 375 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 376 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 377 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 378 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 379 INDIA: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 380 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 381 INDIA: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 382 INDIA: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4.4 ROAPAC
TABLE 383 ROAPAC: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 384 ROAPAC: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 385 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 386 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 387 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 388 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 389 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 390 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 391 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 392 ROAPAC: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 393 ROAPAC: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 394 ROAPAC: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS AND GROWING GOVERNMENT INVESTMENTS TO SUPPORT THE MARKET GROWTH
TABLE 395 LATAM: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 396 LATAM: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 397 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 398 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 399 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 400 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 401 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 402 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 403 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 404 LATAM: PROTEIN CHARACTERIZATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 405 LATAM: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 406 LATAM: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWTH IN THE PHARMACEUTICAL MARKET AND EXPANSION BY TOP PHARMACEUTICAL COMPANIES TO PROMOTE GROWTH OF MARKET
TABLE 407 MEA: PROTEIN CHARACTERIZATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 408 MEA: PROTEIN IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 409 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 410 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 411 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 412 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 413 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 414 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 415 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 416 MEA: PROTEIN IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 417 MEA: PROTEIN CHARACTERIZATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 418 MEA: PROTEIN IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 264)
10.1 INTRODUCTION
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 28 PROTEIN CHARACTERIZATION MARKET: STRATEGIES ADOPTED
10.3 REVENUE ANALYSIS
FIGURE 29 REVENUE ANALYSIS FOR KEY COMPANIES OVER THE PAST THREE YEARS
10.4 MARKET SHARE ANALYSIS
FIGURE 30 PROTEIN IDENTIFICATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 31 PROTEIN CHARACTERIZATION MARKET: COMPANY EVALUATION MATRIX, 2020
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 PROTEIN IDENTIFICATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2020
10.7 COMPETITIVE BENCHMARKING
10.7.1 COMPANY PRODUCT & SERVICE FOOTPRINT (20 COMPANIES)
FIGURE 33 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PROTEIN CHARACTERIZATION MARKET
10.7.2 COMPANY PRODUCT & SERVICE OFFERING FOOTPRINT (20 COMPANIES)
TABLE 419 PRODUCT & SERVICE OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PROTEIN IDENTIFICATION MARKET
10.7.3 COMPANY REGIONAL FOOTPRINT (20 COMPANIES)
TABLE 420 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PROTEIN CHARACTERIZATION MARKET
10.8 COMPETITIVE SCENARIO AND TRENDS
10.8.1 PRODUCT & SERVICE LAUNCHES
TABLE 421 PROTEIN IDENTIFICATION MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2017–AUGUST 2021
10.8.2 DEALS
TABLE 422 PROTEIN CHARACTERIZATION MARKET: DEALS, JANUARY 2017–AUGUST 2021
11 COMPANY PROFILES (Page No. - 277)
11.1 KEY COMPANIES
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 DANAHER CORPORATION
TABLE 423 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 424 DANAHER CORPORATION: PRODUCT OFFERINGS
11.1.2 MERCK KGAA
TABLE 425 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT
TABLE 426 MERCK KGAA: PRODUCT & SERVICE OFFERINGS
11.1.3 THERMO FISHER SCIENTIFIC
TABLE 427 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 428 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
11.1.4 AGILENT TECHNOLOGIES
TABLE 429 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 37 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 430 AGILENT TECHNOLOGIES: PRODUCT OFFERINGS
11.1.5 WATERS CORPORATION
TABLE 431 WATERS CORPORATION: BUSINESS OVERVIEW
FIGURE 38 WATERS CORPORATION: COMPANY SNAPSHOT
TABLE 432 WATERS CORPORATION: PRODUCTS & SERVICE OFFERINGS
11.1.6 BIO-RAD LABORATORIES
TABLE 433 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 39 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
TABLE 434 BIO-RAD LABORATORIES: PRODUCT OFFERINGS
11.1.7 BRUKER CORPORATION
TABLE 435 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 40 BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 436 BRUKER CORPORATION: PRODUCT OFFERINGS
11.1.8 PERKINELMER
TABLE 437 PERKINELMER: BUSINESS OVERVIEW
FIGURE 41 PERKINELMER: COMPANY SNAPSHOT
TABLE 438 PERKINELMER: PRODUCT OFFERINGS
11.1.9 SHIMADZU CORPORATION
TABLE 439 SHIMADZU CORPORATION: BUSINESS OVERVIEW
FIGURE 42 SHIMADZU CORPORATION: COMPANY SNAPSHOT
TABLE 440 SHIMADZU CORPORATION: PRODUCT OFFERINGS
11.1.10 EUROFINS SCIENTIFIC
TABLE 441 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 442 EUROFINS SCIENTIFIC: SERVICE OFFERINGS
11.1.11 SARTORIUS
TABLE 443 SARTORIUS: BUSINESS OVERVIEW
FIGURE 44 SARTORIUS: COMPANY SNAPSHOT
TABLE 444 SARTORIUS AG: PRODUCT OFFERINGS
11.1.12 HORIBA
TABLE 445 HORIBA: BUSINESS OVERVIEW
FIGURE 45 HORIBA: COMPANY SNAPSHOT
TABLE 446 HORIBA: PRODUCT OFFERINGS
11.1.13 QIAGEN
TABLE 447 QIAGEN: BUSINESS OVERVIEW
FIGURE 46 QIAGEN: COMPANY SNAPSHOT
TABLE 448 QIAGEN: PRODUCT OFFERINGS
11.1.14 VPROTEOMICS
TABLE 449 VPROTEOMICS: BUSINESS OVERVIEW
TABLE 450 VPROTEOMICS: SERVICE OFFERINGS
11.1.15 JEOL
TABLE 451 JEOL: BUSINESS OVERVIEW
FIGURE 47 JEOL: COMPANY SNAPSHOT
TABLE 452 JEOL: PRODUCT OFFERINGS
11.1.16 PROMEGA CORPORATION
TABLE 453 PROMEGA CORPORATION: BUSINESS OVERVIEW
TABLE 454 PROMEGA CORPORATION: PRODUCT OFFERINGS
11.1.17 CLEAVER SCIENTIFIC
TABLE 455 CLEAVER SCIENTIFIC: BUSINESS OVERVIEW
TABLE 456 CLEAVER SCIENTIFIC: PRODUCT OFFERINGS
11.1.18 SERVA ELECTROPHORESIS
TABLE 457 SERVA ELECTROPHORESIS: BUSINESS OVERVIEW
TABLE 458 SERVA ELECTROPHORESIS: PRODUCT OFFERINGS
11.1.19 ANALYTIK JENA
TABLE 459 ANALYTIK JENA GMBH: BUSINESS OVERVIEW
TABLE 460 ANALYTIK JENA: PRODUCT OFFERINGS
11.1.20 RIGAKU CORPORATION
TABLE 461 RIGAKU CORPORATION: BUSINESS OVERVIEW
TABLE 462 RIGAKU CORPORATION: PRODUCT OFFERINGS
11.1.21 LECO CORPORATION
TABLE 463 LECO CORPORATION: BUSINESS OVERVIEW
TABLE 464 LECO CORPORATION: PRODUCT OFFERINGS
11.1.22 MASSTECH
TABLE 465 MASSTECH: BUSINESS OVERVIEW
TABLE 466 MASSTECH: PRODUCT OFFERINGS
11.1.23 MS BIOWORKS
TABLE 467 MS BIOWORKS: BUSINESS OVERVIEW
TABLE 468 MS BIOWORKS: SERVICE OFFERINGS
11.1.24 ADVION
TABLE 469 ADVION: BUSINESS OVERVIEW
TABLE 470 ADVION: PRODUCT OFFERINGS
11.1.25 CREATIVE PROTEOMICS
TABLE 471 CREATIVE PROTEOMICS: BUSINESS OVERVIEW
TABLE 472 CREATIVE PROTEOMICS: SERVICES OFFERINGS
11.2 OTHER COMPANIES
11.2.1 POOCHON SCIENTIFIC
11.2.2 TECAN GROUP
11.2.3 PROTEOME FACTORY AG
11.2.4 APPLIED BIOMICS
11.2.5 BIOPROXIMITY
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 347)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORT
12.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global protein characterization market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the protein identification market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Data
The secondary sources referred to for this research study include publications from government sources, such as the World Bank, World Health Organization, Centers for Disease Control and Prevention (CDC), American Public Health Association (APHA), Economist Intelligence Unit, European Proteomics Association, American Society for Mass Spectrometry (ASMS), and the International Mass Spectrometry Foundation (IMSF). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global Protein characterization market, which was validated through primary research.
Primary Data
Extensive primary research was conducted after acquiring basic knowledge about the global protein identification market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & biotechnology companies, CROs, and academic research institutes) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others from tier 1 and tier 2 companies engaged in offering product in protein characterization market) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Primary research was used in this report to:
- Validate the market segmentation defined through a product and service portfolio assessment of the leading players in the protein identification market
- Understand key industry trends and issues defining the strategic growth objectives of market players
- Gather both demand- and supply-side validation of the key factors affecting the market growth (such as market drivers, restraints, challenges, and opportunities)
- Validate assumptions for the market sizing and forecasting model used for this study
- Understand the market position of leading players in the protein characterization market and their market shares/rankings
To know about the assumptions considered for the study, download the pdf brochure
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the protein identification market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the protein characterization market
Report Objectives
- To define, describe, and forecast the global protein identification market based on product & service, application, end user, and region.
- To provide detailed information on the major factors influencing the market growth (such as drivers, challenges, and opportunities).
- To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall protein characterization market.
- To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders.
- To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To profile the key players and comprehensively analyze their market shares and core competencies.
- To track and analyze competitive developments such as new service launches; acquisitions; expansions; and partnerships, collaborations, and agreements
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the rest of Europe market, by country
- Further breakdown of the rest of Asia Pacific market, by country
- Further breakdown of the Latin American and Middle Eastern & African market, by country
Company Information
Detailed analysis and profiling of additional market players (up to 5) inclusive of:
- Business Overview
- Financial Information
- Product Offered
- Developments (Last three years)
Generating Response ...
Growth opportunities and latent adjacency in Protein Characterization Market